Brief: Prometheus Biosciences Posts Quarterly Loss Per Share Of $1.67
May 13 (Reuters) - Prometheus Biosciences Inc RXDX.O :
* PROMETHEUS BIOSCIENCES REPORTS FIRST QUARTER 2021
FINANCIAL
RESULTS AND PROVIDES A CORPORATE UPDATE
* PROMETHEUS BIOSCIENCES - QTRLY LOSS PER SHARE $1.67
* PROMETHEUS BIOSCIENCES - AS OF MARCH 31, 2021, HAD CASH,
EQUIVALENTS OF $311.2 MILLION VERSUS $54.2 MILLION AT END OF
2020
Source text for Eikon: ID:nGNX6Y156d
Further company coverage: RXDX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Prometheus Biosciences
See all newsBrief: Prometheus Biosciences - Completed Merger Of Splash Merger Sub, Unit Of Merck & Co
Analysis: Amgen's antitrust woes spur wider pharmaceutical deal fears
William Blair sees FTC suit on Amgen-Horizon deal weighing on biotech M&A sentiment
FTC scrutiny to block Amgen-Horizon deal drags down Seagen, Prometheus
Brief: Prometheus Biosciences Reports First Quarter 2023 Financial Results